Company / Total Assets
Ligand Pharmaceuticals, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.6B
FY2025
5-year range
$762.7M / $1.6B
FY2021-FY2025
Trend
+65.7%
vs FY2024
Sector context
#51 of 214
Health Care
What the data says
Ligand Pharmaceuticals, Inc.'s total assets of $1.6B is higher than 76% of companies in the Health Care sector (FY2025). Total Assets has increased for 3 consecutive years, from $763M in FY2022 to $1.6B in FY2025.
Based on SEC 10-K filings.
$1.6B in FY2025 with a 5-year CAGR of +2.8%. Top quartile in the Health Care sector.
Improved from $787M to $1.6B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +27.0%
- 5-Year CAGR
- +2.8%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 214This company $1.6B Sector average $7.5B
▼
-79.1% below sector average
Key checks
Key Insights
- Ligand Pharmaceuticals, Inc.'s total assets has grown for 3 consecutive years.
- 5-year CAGR of +2.8%, indicating consistent growth.
- In FY2025, total assets increased 65.7% year-over-year.
- Ranks #51 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6B | +65.7% |
| FY2024 | $941.8M | +19.6% |
| FY2023 | $787.2M | +3.2% |
| FY2022 | $762.7M | -41.2% |
| FY2021 | $1.3B | -4.7% |
| FY2020 | $1.4B | -8.9% |
| FY2019 | $1.5B | +18.6% |
| FY2018 | $1.3B | +87.9% |
| FY2017 | $671.0M | +11.5% |
| FY2016 | $601.6M | +19.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026